Literature DB >> 23267066

Neddylation pathway regulates T-cell function by targeting an adaptor protein Shc and a protein kinase Erk signaling.

Hyung-seung Jin1, Lujian Liao, Yoon Park, Yun-Cai Liu.   

Abstract

NEDD8 (neural precursor cell expressed, developmentally down-regulated 8) is a ubiquitin-like molecule whose action on modifying protein substrates is critical in various cellular functions but whose importance in the immune system is not well understood. Here we investigated the role of protein neddylation in regulating T-cell function using an in vivo knockdown technique. We found that reduced expression of Ubc12 in CD4(+) T cells led to impaired T-cell receptor/CD28-induced proliferation and cytokine production both in vitro and in vivo, accompanied by reduced Erk activation. These findings were recapitulated by treatment with MLN4924, an inhibitor of NEDD8-activating enzyme. Furthermore, Shc, an adaptor molecule between antigen receptors and the Ras/Erk pathway, was identified as a target for neddylation. Importantly, mice adoptively transferred with Ubc12 knockdown CD4(+) T cells showed markedly ameliorated allergic responses. This study thus identifies an important role for protein neddylation in T-cell function, which may serve as a therapeutic target for inflammatory diseases.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23267066      PMCID: PMC3545825          DOI: 10.1073/pnas.1213819110

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  14 in total

Review 1.  Structural complexity in ubiquitin recognition.

Authors:  J Wade Harper; Brenda A Schulman
Journal:  Cell       Date:  2006-03-24       Impact factor: 41.582

Review 2.  Modification of proteins by ubiquitin and ubiquitin-like proteins.

Authors:  Oliver Kerscher; Rachael Felberbaum; Mark Hochstrasser
Journal:  Annu Rev Cell Dev Biol       Date:  2006       Impact factor: 13.827

3.  Nedd8 modification of cul-1 activates SCF(beta(TrCP))-dependent ubiquitination of IkappaBalpha.

Authors:  M A Read; J E Brownell; T B Gladysheva; M Hottelet; L A Parent; M B Coggins; J W Pierce; V N Podust; R S Luo; V Chau; V J Palombella
Journal:  Mol Cell Biol       Date:  2000-04       Impact factor: 4.272

4.  NEDD8-targeting drug MLN4924 elicits DNA rereplication by stabilizing Cdt1 in S phase, triggering checkpoint activation, apoptosis, and senescence in cancer cells.

Authors:  Jie Jessie Lin; Michael A Milhollen; Peter G Smith; Usha Narayanan; Anindya Dutta
Journal:  Cancer Res       Date:  2010-12-15       Impact factor: 12.701

5.  The NEDD8 Conjugation Pathway and Its Relevance in Cancer Biology and Therapy.

Authors:  Teresa A Soucy; Lawrence R Dick; Peter G Smith; Michael A Milhollen; James E Brownell
Journal:  Genes Cancer       Date:  2010-07

Review 6.  Role of Shc in T-cell development and function.

Authors:  Li Zhang; Ulrike Lorenz; Kodi S Ravichandran
Journal:  Immunol Rev       Date:  2003-02       Impact factor: 12.988

Review 7.  T cell activation.

Authors:  Jennifer E Smith-Garvin; Gary A Koretzky; Martha S Jordan
Journal:  Annu Rev Immunol       Date:  2009       Impact factor: 28.527

8.  An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer.

Authors:  Teresa A Soucy; Peter G Smith; Michael A Milhollen; Allison J Berger; James M Gavin; Sharmila Adhikari; James E Brownell; Kristine E Burke; David P Cardin; Stephen Critchley; Courtney A Cullis; Amanda Doucette; James J Garnsey; Jeffrey L Gaulin; Rachel E Gershman; Anna R Lublinsky; Alice McDonald; Hirotake Mizutani; Usha Narayanan; Edward J Olhava; Stephane Peluso; Mansoureh Rezaei; Michael D Sintchak; Tina Talreja; Michael P Thomas; Tary Traore; Stepan Vyskocil; Gabriel S Weatherhead; Jie Yu; Julie Zhang; Lawrence R Dick; Christopher F Claiborne; Mark Rolfe; Joseph B Bolen; Steven P Langston
Journal:  Nature       Date:  2009-04-09       Impact factor: 49.962

9.  Structural insights into NEDD8 activation of cullin-RING ligases: conformational control of conjugation.

Authors:  David M Duda; Laura A Borg; Daniel C Scott; Harold W Hunt; Michal Hammel; Brenda A Schulman
Journal:  Cell       Date:  2008-09-19       Impact factor: 41.582

Review 10.  Immunity by ubiquitylation: a reversible process of modification.

Authors:  Yun-Cai Liu; Josef Penninger; Michael Karin
Journal:  Nat Rev Immunol       Date:  2005-12       Impact factor: 53.106

View more
  36 in total

1.  SAG/Rbx2-Dependent Neddylation Regulates T-Cell Responses.

Authors:  Nathan D Mathewson; Hideaki Fujiwara; Shin-Rong Wu; Tomomi Toubai; Katherine Oravecz-Wilson; Yaping Sun; Corinne Rossi; Cynthia Zajac; Yi Sun; Pavan Reddy
Journal:  Am J Pathol       Date:  2016-08-18       Impact factor: 4.307

Review 2.  Targeting Neddylation pathways to inactivate cullin-RING ligases for anticancer therapy.

Authors:  Yongchao Zhao; Meredith A Morgan; Yi Sun
Journal:  Antioxid Redox Signal       Date:  2014-02-20       Impact factor: 8.401

Review 3.  Regulation of T cell receptor complex-mediated signaling by ubiquitin and ubiquitin-like modifications.

Authors:  Samantha F Friend; Francina Deason-Towne; Lisa K Peterson; Allison J Berger; Leonard L Dragone
Journal:  Am J Clin Exp Immunol       Date:  2014-12-05

4.  Inhibition of neddylation ameliorates DSS-induced colitis.

Authors:  Ping Wan; Xiao-Dan Zhu; Xiao-Peng Liu; Tao Yu; Run-Wei Yan; Yuan Guo; Ai-Ping Bai
Journal:  Cell Mol Immunol       Date:  2018-01-29       Impact factor: 11.530

5.  Inhibition of atherogenesis by the COP9 signalosome subunit 5 in vivo.

Authors:  Yaw Asare; Miriam Ommer; Florence A Azombo; Setareh Alampour-Rajabi; Marieke Sternkopf; Maryam Sanati; Marion J Gijbels; Corinna Schmitz; Dzmitry Sinitski; Pathricia V Tilstam; Hongqi Lue; André Gessner; Denise Lange; Johannes A Schmid; Christian Weber; Martin Dichgans; Joachim Jankowski; Ruggero Pardi; Menno P J de Winther; Heidi Noels; Jürgen Bernhagen
Journal:  Proc Natl Acad Sci U S A       Date:  2017-03-14       Impact factor: 11.205

6.  MLN4924, an NAE inhibitor, suppresses AKT and mTOR signaling via upregulation of REDD1 in human myeloma cells.

Authors:  Yanyan Gu; Jonathan L Kaufman; Leon Bernal; Claire Torre; Shannon M Matulis; R Donald Harvey; Jing Chen; Shi-Yong Sun; Lawrence H Boise; Sagar Lonial
Journal:  Blood       Date:  2014-04-08       Impact factor: 22.113

7.  CD4 aptamer-RORγt shRNA chimera inhibits IL-17 synthesis by human CD4(+) T cells.

Authors:  Pingfang Song; Yuan K Chou; Xiaowei Zhang; Roberto Meza-Romero; Kentaro Yomogida; Gil Benedek; Cong-Qiu Chu
Journal:  Biochem Biophys Res Commun       Date:  2014-09-18       Impact factor: 3.575

Review 8.  Protein neddylation and its alterations in human cancers for targeted therapy.

Authors:  Lisha Zhou; Wenjuan Zhang; Yi Sun; Lijun Jia
Journal:  Cell Signal       Date:  2018-01-10       Impact factor: 4.315

9.  Immunomodulatory effects of pevonedistat, a NEDD8-activating enzyme inhibitor, in chronic lymphocytic leukemia-derived T cells.

Authors:  Scott Best; Vi Lam; Tingting Liu; Nur Bruss; Adam Kittai; Olga V Danilova; Susan Murray; Allison Berger; Nathan D Pennock; Evan F Lind; Alexey V Danilov
Journal:  Leukemia       Date:  2020-03-16       Impact factor: 11.528

10.  SHARPIN controls regulatory T cells by negatively modulating the T cell antigen receptor complex.

Authors:  Yoon Park; Hyung-Seung Jin; Justine Lopez; Jeeho Lee; Lujian Liao; Chris Elly; Yun-Cai Liu
Journal:  Nat Immunol       Date:  2016-02-01       Impact factor: 25.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.